Abstract
Combinations of DNA and recombinant-viral-vector based vaccines are promising AIDS vaccine methods because of their potential for inducing cellular immune responses. It was found that Gag-specific cytotoxic lymphocyte (CTL) responses were associated with lowering viremia in an untreated HIV-1 infected cohort. The main objectives of our studies were the construction of DNA and recombinant Sendai virus vector (rSeV) vaccines containing a gag gene from the prevalent Thailand subtype B strain in China and trying to use these vaccines for therapeutic and prophylactic vaccines. The candidate plasmid DNA vaccine pcDNA3.1(+)-gag and recombinant Sendai virus vaccine (rSeV-gag) were constructed separately. It was verified by Western blotting analysis that both DNA and rSeV-gag vaccines expressed the HIV-1 Gag protein correctly and efficiently. Balb/c mice were immunized with these two vaccines in different administration schemes. HIV-1 Gag-specific CTL responses and antibody levels were detected by intracellular cytokine staining assay and enzyme-linked immunosorbant assay (ELISA) respectively. Combined vaccines in a DNA prime/rSeV-gag boost vaccination regimen induced the strongest and most long-lasting Gag-specific CTL and antibody responses. It maintained relatively high levels even 9 weeks post immunization. This data indicated that the prime-boost regimen with DNA and rSeV-gag vaccines may offer promising HIV vaccine regimens.
Article PDF
Similar content being viewed by others
References
Altfeld M, Rosenberg E S. 2000. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr Opin Immunol, 12(4): 375–380.
Amara R R, Villinger F, Altman J D, et al. 2001. Control of a mucosal challenge and prevention of AIDS by a multi protein DNA/MVA vaccine. Science, 292(5514): 69–74.
Andre S, Seed B, Eberle J, et al. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol, 72(2): 1497–1503.
Betts M R, Ambrozak D R, Douek D C, et al. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4 (+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol, 75(24):11983–1991.
Bitzer M, Armeanu S, Lauer U M, et al. 2003. Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med, 5(7): 543–553.
Borrow P, Lewicki H, Hahn B H, et al. 1994. Virusspecific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol, 68(9): 6103–6110.
Geldmacher C, Currier J R, Herrmann E, et al. 2007. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol, 81(5): 2440–2448.
Hasan M K, Kato A, Shioda T, et al. 1997. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J Gen Virol, 78: 2813–2820
Im E J, Nkolola J P, di Gleria K, et al. 2006. Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques. Eur J Immunol, 36(10):2574–2584.
Kano M, Matano T, Nakamura H, et al. 2000. Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein. AIDS, 14(9): 1281–1282.
Kano M, Matano T, Kato A, et al. 2002. Primary replication of a recombinant Sendai virus vector in macaques. J Gen Virol, 83(Pt6): 1377–1386.
Kato A, Sakai Y, Shioda T, et al. 1996. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells, 1: 569–579.
Kiepiela P, Nqumbela K, Thobakqale C, et al. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med, 13(1): 46–53.
Kong W, Tian C, Liu B, et al. 2002. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector. J Virol, 76(22): 11434–11439.
Leligdowicz A, Yindom L M, Onyango C, et al. 2007. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest, 117(10): 3067–3074.
Novitsky V, Cao H, Rybak N, et al. 2002. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol, 76(20): 10155–10168.
Prince A M, Whalen R, Brotman B. 1997. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine, 15(8): 916–919.
Schoenly K A, Weiner D B. 2008. Human immunodeficiency virus type 1 Vaccine Development: recent Advances in the CTL Platform “Spotty Business”. J Virol, 82(7): 3166–3180.
Takeda A, Igarashi H, Nakamura H, et al. 2003. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J Virol, 77(17): 9710–9715.
Toapanta F R, Craigo J K, Montelaro R C, et al. 2007. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Curr HIV Res, 25(2): 199–209.
Urwitz J L, Soike K F, Sangster M Y, et al. 1997. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virustype one. Vaccine, 15(5): 533–540.
Wolff J A, Malone R W, Williams P, et al. 1990. Direct gene transfer into mouse muscle in vivo. Science, 247(4949Pt1): 1465–1468.
Yasutomi Y, Reimann K A, Lord C I, et al. 1993. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol, 67(3): 1707–1711.
Yu D, Shioda T, Kato A, et al. 1997. Sendai virus-based expression of HIV-1 gp120: reinforcement by the V (-) version. Genes Cells, 2: 457–466.
zur Megede J, Chen M C, Doe B, et al. 2000. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J Virol, 74(6): 2628–2635.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Foundation item: National 863 project (2003AA219070)
Rights and permissions
About this article
Cite this article
Feng, X., Yu, Sq., Shu, T. et al. Immunogenicity of DNA and recombinant Sendai virus vaccines expressing the HIV-1 gag gene. Virol. Sin. 23, 295–304 (2008). https://doi.org/10.1007/s12250-008-2946-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-008-2946-y